Pulmonary function test results are correlated with 6-minute walk distance, distance-saturation product, and 6-minute walk work in patients with lymphangioleiomyomatosis

IF 2.2 4区 医学 Q3 RESPIRATORY SYSTEM Respiratory Medicine and Research Pub Date : 2023-11-28 DOI:10.1016/j.resmer.2023.101071
Rémi Diesler , Vincent Cottin , Yves Gallien , Ségolène Turquier , Julie Traclet , Kais Ahmad , Jean-Charles Glerant
{"title":"Pulmonary function test results are correlated with 6-minute walk distance, distance-saturation product, and 6-minute walk work in patients with lymphangioleiomyomatosis","authors":"Rémi Diesler ,&nbsp;Vincent Cottin ,&nbsp;Yves Gallien ,&nbsp;Ségolène Turquier ,&nbsp;Julie Traclet ,&nbsp;Kais Ahmad ,&nbsp;Jean-Charles Glerant","doi":"10.1016/j.resmer.2023.101071","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and objective</h3><p><span>Lymphangioleiomyomatosis<span><span> (LAM) is a rare multicystic lung disease. Although a correlation between </span>pulmonary function test (PFT) results and exercise capacity appears probable, it has not yet been demonstrated. The aim of this study was to assess whether PFT results correlate with 6-minute walk test (6MWT) results </span></span>in patients with LAM.</p></div><div><h3>Methods</h3><p>We conducted a retrospective study of all patients with a diagnosis of LAM followed in a French reference centre over a 13-year period. PFT and 6MWT data were collected. Distance-saturation product (DSP) and 6-minute walk work (6MWORK) were calculated.</p></div><div><h3>Results</h3><p><span><span>A total of 62 patients were included. Their median forced expiratory volume in 1 s (FEV1) was 82.7 % predicted and their median </span>forced vital capacity<span> (FVC) was 96.7 % predicted. The median diffusing capacity<span> of the lungs for carbon monoxide (DLCO) was 58.5 % predicted and was decreased in 79 % of the patients. The median 6-minute walk distance was 535 m, which was 90.9 % of the 602 m predicted distance. The median DSP was 497.4 m % and the median 6MWORK was 32,910 kg.m. The distance walked during the 6MWT was significantly correlated with FVC%predicted (</span></span></span><em>R</em> = 0.435), FEV1 %predicted (<em>R</em> = 0.303), TLC%predicted (<em>R</em> = 0.345), FRC%predicted (<em>R</em> = 0.262), RV/TLC ratio (<em>R</em> = -0.271), and DLCO%predicted (<em>R</em> = 0.279). DSP and 6MWORK were each significantly correlated with different PFT results.</p></div><div><h3>Conclusion</h3><p>The present study shows that PFT results are potential predictors of the exercise capacity in patients with LAM. Additional studies are required to evaluate the interest of DSP and 6MWORK in LAM.</p></div>","PeriodicalId":48479,"journal":{"name":"Respiratory Medicine and Research","volume":"85 ","pages":"Article 101071"},"PeriodicalIF":2.2000,"publicationDate":"2023-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory Medicine and Research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590041223000831","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Background and objective

Lymphangioleiomyomatosis (LAM) is a rare multicystic lung disease. Although a correlation between pulmonary function test (PFT) results and exercise capacity appears probable, it has not yet been demonstrated. The aim of this study was to assess whether PFT results correlate with 6-minute walk test (6MWT) results in patients with LAM.

Methods

We conducted a retrospective study of all patients with a diagnosis of LAM followed in a French reference centre over a 13-year period. PFT and 6MWT data were collected. Distance-saturation product (DSP) and 6-minute walk work (6MWORK) were calculated.

Results

A total of 62 patients were included. Their median forced expiratory volume in 1 s (FEV1) was 82.7 % predicted and their median forced vital capacity (FVC) was 96.7 % predicted. The median diffusing capacity of the lungs for carbon monoxide (DLCO) was 58.5 % predicted and was decreased in 79 % of the patients. The median 6-minute walk distance was 535 m, which was 90.9 % of the 602 m predicted distance. The median DSP was 497.4 m % and the median 6MWORK was 32,910 kg.m. The distance walked during the 6MWT was significantly correlated with FVC%predicted (R = 0.435), FEV1 %predicted (R = 0.303), TLC%predicted (R = 0.345), FRC%predicted (R = 0.262), RV/TLC ratio (R = -0.271), and DLCO%predicted (R = 0.279). DSP and 6MWORK were each significantly correlated with different PFT results.

Conclusion

The present study shows that PFT results are potential predictors of the exercise capacity in patients with LAM. Additional studies are required to evaluate the interest of DSP and 6MWORK in LAM.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
淋巴管瘤患者的肺功能测试结果与 6 分钟步行距离、距离-饱和度乘积和 6 分钟步行功相关。
背景和目的:淋巴管瘤病是一种罕见的多囊性肺病。虽然肺功能测试(PFT)结果与运动能力之间可能存在相关性,但尚未得到证实。本研究旨在评估肺功能测试结果是否与 LAM 患者的 6 分钟步行测试(6MWT)结果相关:我们对法国一家参考中心 13 年来所有确诊为 LAM 的患者进行了一项回顾性研究。我们收集了肺活量和 6MWT 数据。结果:共纳入 62 名患者:结果:共纳入 62 名患者。他们 1 秒用力呼气容积(FEV1)的中位数预测值为 82.7%,用力肺活量(FVC)的中位数预测值为 96.7%。肺部一氧化碳弥散能力(DLCO)的中位数预测值为 58.5%,79% 的患者都出现了下降。6 分钟步行距离中位数为 535 米,是预测距离 602 米的 90.9%。中位 DSP 为 497.4 m %,中位 6MWORK 为 32,910 kg.m。435)、预测 FEV1%(R = 0.303)、预测 TLC%(R = 0.345)、预测 FRC%(R = 0.262)、RV/TLC 比值(R = -0.271)和预测 DLCO%(R = 0.279)显著相关。DSP和6MWORK分别与不同的PFT结果呈显著相关:本研究表明,PFT 结果是 LAM 患者运动能力的潜在预测指标。需要进行更多的研究来评估 DSP 和 6MWORK 对 LAM 的意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Respiratory Medicine and Research
Respiratory Medicine and Research RESPIRATORY SYSTEM-
CiteScore
2.70
自引率
0.00%
发文量
82
审稿时长
50 days
期刊最新文献
Efficacy of convalescent plasma for the treatment of COVID-19 in lung transplant recipients: A multicenter French study. Prognosis of incidental lung cancer in lung transplant candidates. Evaluation of efficacy and safety of rituximab in patients with progressive interstitial lung disease (ILD) with inflammatory component (EvER-ILD2): A multicentre double-blind placebo-controlled randomized trial. Pleural ultrasound for pneumothorax diagnosis after computerised tomography-guided biopsy Physical activity and idiopathic pulmonary fibrosis: A prospective cohort study in UK Biobank and Mendelian randomization analyses
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1